Signatur Biosciences raised €6.2M in a funding round in May 2025. The company is based in London, UK. Investors in the round: Noshaq, strategic backers, The Discovery Lab of IBA. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
